NCT04455464View on ClinicalTrials.gov

Effect of Midodrine on HVPG in Advanced Chronic Liver Disease

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 11, 2020

Primary Completion Date

December 13, 2021

Study Completion Date

December 13, 2021

Conditions
Chronic Liver Disease
Interventions
DRUG

Midodrine Oral Tablet

Midodrine will be given 10 mg for one time only.

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT04455464 - Effect of Midodrine on HVPG in Advanced Chronic Liver Disease | Biotech Hunter | Biotech Hunter